Tags

Type your tag names separated by a space and hit enter

The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?
Diabetes. 2014 Jan; 63(1):332-342.D

Abstract

Epidemiological evidence supports a direct and causal association between lipoprotein(a) [Lp(a)] levels and coronary risk, but the nature of the association between Lp(a) levels and risk of type 2 diabetes (T2D) is unclear. In this study, we assessed the association of Lp(a) levels with risk of incident T2D and tested whether Lp(a) levels are causally linked to T2D. We analyzed data on 18,490 participants from the European Prospective Investigation of Cancer (EPIC)-Norfolk cohort that included adults aged 40-79 years at baseline 1993-1997. During an average 10 years of follow-up, 593 participants developed incident T2D. Cox regression models were used to estimate the association between Lp(a) levels and T2D. In Mendelian randomization analyses, based on EPIC-Norfolk combined with DIAbetes Genetics Replication And Meta-analysis data involving a total of 10,088 diabetes case participants and 68,346 control participants, we used a genetic variant (rs10455872) as an instrument to test whether the association between Lp(a) levels and T2D is causal. In adjusted analyses, there was an inverse association between Lp(a) levels and T2D: hazard ratio was 0.63 (95% CI 0.49-0.81; P trend = 0.003) comparing the top versus bottom quintile of Lp(a). In EPIC-Norfolk, a 1-SD increase in logLp(a) was associated with a lower risk of T2D (odds ratio [OR] 0.88 [95% CI: 0.80-0.95]). However, in Mendelian randomization analyses, a 1-SD increase in logLp(a) due to rs10455872, which explained 26.8% of the variability in Lp(a) levels, was not associated with risk of T2D (OR 1.03 [0.96-1.10]; P = 0.41). These prospective findings demonstrate a strong inverse association of Lp(a) levels with risk of T2D. However, a genetic variant that elevated Lp(a) levels was not associated with risk of T2D, suggesting that elevated Lp(a) levels are not causally associated with a lower risk of T2D.

Authors+Show Affiliations

MRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, UK.Department of Public Health and Primary Care, University of Cambridge, UK.Department of Public Health and Primary Care, University of Cambridge, UK. Genetic Epidemiology Group, Wellcome Trust Sanger Institute, Hinxton, UK.Department of Public Health and Primary Care, University of Cambridge, UK. Genetic Epidemiology Group, Wellcome Trust Sanger Institute, Hinxton, UK.Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands.Vascular Medicine Program, University of California, San Diego, 9500 Gilman Drive, La Jolla CA, USA.Department of Public Health and Primary Care, University of Cambridge, UK.MRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, UK.Department of Public Health and Primary Care, University of Cambridge, UK. Genetic Epidemiology Group, Wellcome Trust Sanger Institute, Hinxton, UK.MRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, UK.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24089516

Citation

Ye, Zheng, et al. "The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal?" Diabetes, vol. 63, no. 1, 2014, pp. 332-342.
Ye Z, Haycock PC, Gurdasani D, et al. The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? Diabetes. 2014;63(1):332-342.
Ye, Z., Haycock, P. C., Gurdasani, D., Pomilla, C., Boekholdt, S. M., Tsimikas, S., Khaw, K. T., Wareham, N. J., Sandhu, M. S., & Forouhi, N. G. (2014). The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? Diabetes, 63(1), 332-342. https://doi.org/10.2337/db13-1144
Ye Z, et al. The Association Between Circulating Lipoprotein(a) and Type 2 Diabetes: Is It Causal. Diabetes. 2014;63(1):332-342. PubMed PMID: 24089516.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? AU - Ye,Zheng, AU - Haycock,Philip C, AU - Gurdasani,Deepti, AU - Pomilla,Cristina, AU - Boekholdt,S Matthijs, AU - Tsimikas,Sotirios, AU - Khaw,Kay-Tee, AU - Wareham,Nicholas J, AU - Sandhu,Manjinder S, AU - Forouhi,Nita G, Y1 - 2013/10/02/ PY - 2013/10/4/entrez PY - 2013/10/4/pubmed PY - 2014/2/25/medline SP - 332 EP - 342 JF - Diabetes JO - Diabetes VL - 63 IS - 1 N2 - Epidemiological evidence supports a direct and causal association between lipoprotein(a) [Lp(a)] levels and coronary risk, but the nature of the association between Lp(a) levels and risk of type 2 diabetes (T2D) is unclear. In this study, we assessed the association of Lp(a) levels with risk of incident T2D and tested whether Lp(a) levels are causally linked to T2D. We analyzed data on 18,490 participants from the European Prospective Investigation of Cancer (EPIC)-Norfolk cohort that included adults aged 40-79 years at baseline 1993-1997. During an average 10 years of follow-up, 593 participants developed incident T2D. Cox regression models were used to estimate the association between Lp(a) levels and T2D. In Mendelian randomization analyses, based on EPIC-Norfolk combined with DIAbetes Genetics Replication And Meta-analysis data involving a total of 10,088 diabetes case participants and 68,346 control participants, we used a genetic variant (rs10455872) as an instrument to test whether the association between Lp(a) levels and T2D is causal. In adjusted analyses, there was an inverse association between Lp(a) levels and T2D: hazard ratio was 0.63 (95% CI 0.49-0.81; P trend = 0.003) comparing the top versus bottom quintile of Lp(a). In EPIC-Norfolk, a 1-SD increase in logLp(a) was associated with a lower risk of T2D (odds ratio [OR] 0.88 [95% CI: 0.80-0.95]). However, in Mendelian randomization analyses, a 1-SD increase in logLp(a) due to rs10455872, which explained 26.8% of the variability in Lp(a) levels, was not associated with risk of T2D (OR 1.03 [0.96-1.10]; P = 0.41). These prospective findings demonstrate a strong inverse association of Lp(a) levels with risk of T2D. However, a genetic variant that elevated Lp(a) levels was not associated with risk of T2D, suggesting that elevated Lp(a) levels are not causally associated with a lower risk of T2D. SN - 1939-327X UR - https://www.unboundmedicine.com/medline/citation/24089516/The_association_between_circulating_lipoprotein_a__and_type_2_diabetes:_is_it_causal L2 - https://diabetes.diabetesjournals.org/lookup/pmidlookup?view=long&pmid=24089516 DB - PRIME DP - Unbound Medicine ER -